SDS-PAGE analysis of Aβ oligomers is disserving research into Alzheimer's disease: Appealing for ESI-IM-MS

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Pujol Pina, Rosa ^a   Vilaprinyó Pascual, Sílvia ^a   Mazzucato, Roberta ^a   Arcella, Annalisa ^a   Vilaseca, Marta ^a   Orozco, Modesto ^a,b   Carulla, Natàlia ^a  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; MEDICAL RESEARCH; METABOLISM; MOLECULAR MODEL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCEDURES; PROTEIN MULTIMERIZATION; REPRODUCIBILITY; THERMODYNAMICS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOMEDICAL RESEARCH; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN MULTIMERIZATION; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; THERMODYNAMICS;

EID: 84943595267     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14809     Document Type: Article

References (58)

1. Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112 (2007).
2. Hefti, F. et al. The case for soluble Abeta oligomers as a drug target in Alzheimer's disease. Trends Pharmacol. Sci. 34, 261-266 (2013).
3. Editorial. State of aggregation. Nat. Neurosci. 14, 399 (2011).
4. Benilova, I., Karran, E. & De Strooper, B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci. 15, 349-357 (2012).
5. Bitan, G. et al. Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 100, 330-335 (2003).
6. Necula, M., Kayed, R., Milton, S. & Glabe, C. G. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J. Biol. Chem. 282, 10311-10324 (2007).
7. Bernstein, S. L. et al. Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat. Chem. 1, 326-331 (2009).
8. Yu, L. et al. Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry 48, 1870-1877 (2009).
9. Ahmed, M. et al. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat. Struct. Mol. Biol. 17, 561-567 (2010).
10. Kloniecki, M. et al. Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Abeta1-40 peptide oligomers. J. Mol. Biol. 407, 110-124 (2011).
11. Lee, J., Culyba, E. K., Powers, E. T. & Kelly, J. W. Amyloid-beta forms fibrils by nucleated conformational conversion of oligomers. Nat. Chem. Biol. 7, 602-609 (2011).
12. Narayan, P. et al. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-beta(1-40) peptide. Nat. Struct. Mol. Biol. 19, 79-83 (2012).
13. Bitan, G. & Teplow, D. B. Rapid photochemical cross-linking-a new tool for studies of metastable, amyloidogenic protein assemblies. Acc. Chem. Res. 37, 357-364 (2004).
14. Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67-72 (1997).
15. Blennow, K., Zetterberg, H. & Fagan, A. M. Fluid biomarkers in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006221 (2012).
16. Ono, K., Condron, M. M. & Teplow, D. B. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc. Natl. Acad. Sci. USA 106, 14745-14750 (2009).
17. Paravastu, A. K., Qahwash, I., Leapman, R. D., Meredith, S. C. & Tycko, R. Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc. Natl. Acad. Sci. USA 106, 7443-7448 (2009).
18. Roychaudhuri, R., Yang, M., Hoshi, M. M. & Teplow, D. B. Amyloid beta-protein assembly and Alzheimer disease. J. Biol. Chem. 284, 4749-4753 (2009).
19. Bitan, G., Fradinger, E. A., Spring, S. M. & Teplow, D. B. Neurotoxic protein oligomers-what you see is not always what you get. Amyloid 12, 88-95 (2005).
20. Watt, A. D. et al. Oligomers, fact or artefact? SDS-PAGE induces dimerization of beta-amyloid in human brain samples. Acta Neuropathol. 125, 549-564 (2013).
21. Bernstein, S. L. et al. Amyloid beta-protein: monomer structure and early aggregation states of Abeta42 and its Pro19 alloform. J. Am. Chem. Soc. 127, 2075-2084 (2005).
22. Smith, D. P., Radford, S. E. & Ashcroft, A. E. Elongated oligomers in beta2-microglobulin amyloid assembly revealed by ion mobility spectrometry-mass spectrometry. Proc. Natl. Acad. Sci. USA 107, 6794-6798 (2010).
23. Sitkiewicz, E., Oledzki, J., Poznanski, J. & Dadlez, M. Di-tyrosine cross-link decreases the collisional cross-section of Abeta peptide dimers and trimers in the gas phase: an ion mobility study. PloS one 9, e100200 (2014).
24. Sitkiewicz, E., Kloniecki, M., Poznanski, J., Bal, W. & Dadlez, M. Factors influencing compact-extended structure equilibrium in oligomers of Abeta1-40 peptide-an ion mobility mass spectrometry study. J. Mol. Biol. 426, 2871-2885 (2014).
25. Hernandez, H. & Robinson, C. V. Determining the stoichiometry and interactions of macromolecular assemblies from mass spectrometry. Nat. Protoc. 2, 715-726 (2007).
26. Ayed, A., Krutchinsky, A. N., Ens, W., Standing, K. G. & Duckworth, H. W. Quantitative evaluation of protein-protein and ligandprotein equilibria of a large allosteric enzyme by electrospray ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 12, 339-344 (1998).
27. Gabelica, V., Galic, N., Rosu, F., Houssier, C. & De Pauw, E. Influence of response factors on determining equilibrium association constants of non-covalent complexes by electrospray ionization mass spectrometry. J. Mass Spectrom. 38, 491-501 (2003).
28. Chitta, R. K., Rempel, D. L. & Gross, M. L. Determination of affinity constants and response factors of the noncovalent dimer of gramicidin by electrospray ionization mass spectrometry and mathematical modeling. J. Am. Soc. Mass Spectrom. 16, 1031-1038 (2005).
29. Liu, J. & Konermann, L. Protein-protein binding affinities in solution determined by electrospray mass spectrometry. J. Am. Soc. Mass Spectrom. 22, 408-417 (2011).
30. Boeri Erba, E., Barylyuk, K., Yang, Y. & Zenobi, R. Quantifying protein-protein interactions within noncovalent complexes using electrospray ionization mass spectrometry. Anal. Chem. 83, 9251-9259 (2011).
31. Teplow, D. B. Preparation of amyloid beta-protein for structural and functional studies. Methods Enzymol. 413, 20-33 (2006).
32. Jan, A., Hartley, D. M. & Lashuel, H. A. Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research. Nat. Protoc. 5, 1186-1209 (2010).
33. Bitan, G. Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins. Methods Enzymol. 413, 217-236 (2006).
34. Selkoe, D. J., Abraham, C. R., Podlisny, M. B. & Duffy, L. K. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 46, 1820-1834 (1986).
35. Fancy, D. A. & Kodadek, T. Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. Proc. Natl. Acad. Sci. USA 96, 6020-6024 (1999).
36. Reinke, A. A., Ung, P. M., Quintero, J. J., Carlson, H. A. & Gestwicki, J. E. Chemical probes that selectively recognize the earliest Abeta oligomers in complex mixtures. J. Am. Chem. Soc. 132, 17655-17657 (2010).
37. Petkova, A. T., Yau, W. M. & Tycko, R. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 45, 498-512 (2006).
38. Haupt, C. et al. Structural basis of beta-amyloid-dependent synaptic dysfunctions. Angew. Chem. Int. Ed. Engl. 51, 1576-1579 (2012).
39. Arcella, A. et al. Structure and dynamics of oligonucleotides in the gas phase. Angew. Chem. Int. Ed. Engl. 54, 467-471 (2015).
40. Meyer, T., Gabelica, V., Grubmüller, H. & Orozco, M. Proteins in the gas phase. WIRES Comput. Mol. Sci. 3, 408-425 (2012).
41. Murray, M. M. et al. Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization. J. Am. Chem. Soc. 131, 6316-6317 (2009).
42. Gessel, M. M., Bernstein, S., Kemper, M., Teplow, D. B. & Bowers, M. T. Familial Alzheimer's disease mutations differentially alter amyloid beta-protein oligomerization. ACS Chem. Neurosci. 3, 909-918 (2012).
43. Gessel, M. M. et al. Abeta(39-42) modulates Abeta oligomerization but not fibril formation. Biochemistry 51, 108-117 (2012).
44. Zheng, X. et al. Z-Phe-Ala-diazomethylketone (PADK) disrupts and remodels early oligomer states of the Alzheimer disease Abeta42 protein. J. Biol. Chem. 287, 6084-6088 (2012).
45. Zheng, X. et al. Amyloid beta-protein assembly: The effect of molecular tweezers CLR01 and CLR03. J. Phys Chem. B 119, 4831-4841 (2015).
46. Cukalevski, R. et al. The Aβ 40 and Aβ 42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation. Chem. Sci. 6, 4215-4233 (2015).
47. Lendel, C. et al. A hexameric peptide barrel as building block of amyloid-beta protofibrils. Angew. Chem. Int. Ed. Engl. 53, 12756-12760 (2014).
48. Ruotolo, B. T., Benesch, J. L., Sandercock, A. M., Hyung, S. J. & Robinson, C. V. Ion mobility-mass spectrometry analysis of large protein complexes. Nat. Protoc. 3, 1139-1152 (2008).
49. Smith, D. P. et al. Deciphering drift time measurements from travelling wave ion mobility spectrometry-mass spectrometry studies. Eur. J. Mass. Spectrom. 15, 113-130 (2009).
50. Smith, D. E. & Dang, L. X. Computer simulations of NaCl association in polarizable water. J. Chem. Phys. 100, 3757-3766 (1994).
51. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of Simple Potential Functions for Simulating Liquid Water. J. Chem. Phys. 79, 926-935 (1983).
52. Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950-1958 (2010).
53. York, D. M., Darden, T. A. & Pedersen, L. G. The effect of long-range electrostatic interactions in simulations of macromolecular crystals: A comparison of the Ewald and truncated list methods. J. Chem. Phys. 99, 8345-8348 (1993).
54. Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., Di Nola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684-3690 (1984).
55. Ryckaert, P., Cicotti, G. & Berendsen, H. J. C. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes. J. Comput. Phys. 23, 327-341 (1977).
56. Shvartsburg, A. A. & Jarrold, M. F. An exact hard-spheres scattering model for the mobilities of polyatomic ions. Chem. Phys. Lett. 261, 86-91 (1996).
57. Sugita, Y. & Okamoto, Y. Replica-exchange molecular dynamics method for protein folding. Chem. Phys. Lett. 314, 141-151 (1999).
58. Morsa, D., Gabelica, V. & De Pauw, E. Effective temperature of ions in traveling wave ion mobility spectrometry. Anal. Chem. 83, 5775-5782 (2011).